5-Fluorouracil/Leucovorin Combined with Irinotecan and Oxaliplatin (FOLFIRINOX) as Second-Line Chemotherapy in Patients with Metastatic Pancreatic Adenocarcinoma

Oncology ◽  
2011 ◽  
Vol 80 (5-6) ◽  
pp. 301-306 ◽  
Author(s):  
Elias Assaf ◽  
Muriel Verlinde-Carvalho ◽  
Catherine Delbaldo ◽  
Julien Grenier ◽  
Zineb Sellam ◽  
...  
Keyword(s):  
Pancreatic Adenocarcinoma ◽  
Second Line ◽  
Second Line Chemotherapy ◽  
Metastatic Pancreatic Adenocarcinoma ◽  
Line Chemotherapy

scholarly journals Expanded analysis of mFOLFIRINOX as second-line chemotherapy in pancreatic adenocarcinoma

2017 ◽  
Vol 28 ◽  
pp. iii75
Author(s):  
Andrew Dean ◽  
Domenic Higgs ◽  
Alex James ◽  
Tegan Van Gemert ◽  
Alena James
Keyword(s):  
Pancreatic Adenocarcinoma ◽  
Second Line ◽  
Second Line Chemotherapy ◽  
Line Chemotherapy

scholarly journals Gemcitabine as second-line chemotherapy after Folfirinox failure in advanced pancreatic adenocarcinoma: A retrospective study

2017 ◽  
Vol 49 (6) ◽  
pp. 692-696 ◽  
Author(s):  
Juliette Viaud ◽  
Clémence Brac ◽  
Pascal Artru ◽  
Estelle Le Pabic ◽  
Bérengère Leconte ◽  
...  
Keyword(s):  
Retrospective Study ◽  
Pancreatic Adenocarcinoma ◽  
Second Line ◽  
Second Line Chemotherapy ◽  
Advanced Pancreatic Adenocarcinoma ◽  
Line Chemotherapy

A Case of Duodenal Neuroendocrine Carcinoma Treated with Amrubicin as Second-line Chemotherapy

2015 ◽  
Vol 24 (3) ◽  
pp. 379-382
Author(s):  
Tadahisa Inoue ◽  
Hitoshi Sano ◽  
Takashi Mizushima ◽  
Hirotada Nishie ◽  
Hiroyasu Iwasaki ◽  
...  
Keyword(s):  
Neuroendocrine Carcinoma ◽  
Distant Metastases ◽  
Salvage Chemotherapy ◽  
Second Line ◽  
Effective Treatment Option ◽  
Second Line Chemotherapy ◽  
Best Response ◽  
Long Term Effect ◽  
Line Chemotherapy

We present the case of a Japanese man in his 60s with duodenal neuroendocrine carcinoma with distant metastases. Chemotherapy with irinotecan plus cisplatin was initiated as a first-line regimen. However, disease progression was observed after only two cycles. Therefore, amrubicin was administered as a second-line chemotherapy. The patient showed a long-term effect of amrubicin therapy, and the best response was a partial response after seven cycles. For duodenal neuroendocrine carcinoma, amrubicin therapy can be considered an effective treatment option as salvage chemotherapy.

Sign in / Sign up

Export Citation Format

Share Document